Works by Norimitsu Uza


Results: 36
    1

    Association between homologous recombination gene variants and efficacy of oxaliplatin-based chemotherapy in advanced pancreatic cancer: prospective multicenter observational study.

    Published in:
    Medical Oncology, 2023, v. 40, n. 5, p. 1, doi. 10.1007/s12032-023-02011-y
    By:
    • Kondo, Tomohiro;
    • Kanai, Masashi;
    • Matsubara, Junichi;
    • Yamaguchi, Daisuke;
    • Ura, Takashi;
    • Kou, Tadayuki;
    • Itani, Toshinao;
    • Nomura, Motoo;
    • Funakoshi, Taro;
    • Yokoyama, Akira;
    • Doi, Keitaro;
    • Tamaoki, Masashi;
    • Yoshimura, Michio;
    • Uza, Norimitsu;
    • Yamada, Takahiro;
    • Masui, Toshihiko;
    • Minamiguchi, Sachiko;
    • Matsumoto, Shigemi;
    • Ishikawa, Hideki;
    • Muto, Manabu
    Publication type:
    Article
    2
    3
    4
    5

    Autoimmune Pancreatitis Exhibiting Multiple Mass Lesions.

    Published in:
    Case Reports in Gastroenterology, 2011, v. 5, n. 3, p. 528, doi. 10.1159/000331799
    By:
    • Shiokawa, Masahiro;
    • Kodama, Yuzo;
    • Hiramatsu, Yukiko;
    • Kurita, Akira;
    • Sawai, Yugo;
    • Uza, Norimitsu;
    • Watanabe, Tomohiro;
    • Chiba, Tsutomu
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    Impact of neoadjuvant intensity-modulated radiation therapy on borderline resectable pancreatic cancer with arterial abutment; a prospective, open-label, phase II study in a single institution.

    Published in:
    2022
    By:
    • Masui, Toshihiko;
    • Nagai, Kazuyuki;
    • Anazawa, Takayuki;
    • Sato, Asahi;
    • Uchida, Yuichiro;
    • Nakano, Kenzo;
    • Yogo, Akitada;
    • Kaneda, Akihiro;
    • Nakamura, Naoto;
    • Yoshimura, Michio;
    • Mizowaki, Takashi;
    • Uza, Norimitsu;
    • Fukuda, Akihisa;
    • Matsumoto, Shigemi;
    • Kanai, Masashi;
    • Isoda, Hiroyoshi;
    • Mizumoto, Masaki;
    • Seo, Satoru;
    • Hata, Koichiro;
    • Taura, Kojiro
    Publication type:
    journal article
    12

    Prognostic model for survival based on readily available pretreatment factors in patients with advanced pancreatic cancer receiving palliative chemotherapy.

    Published in:
    International Journal of Clinical Oncology, 2016, v. 21, n. 1, p. 118, doi. 10.1007/s10147-015-0864-x
    By:
    • Kou, Tadayuki;
    • Kanai, Masashi;
    • Yamamoto, Michio;
    • Xue, Peng;
    • Mori, Yukiko;
    • Kudo, Yasushi;
    • Kurita, Akira;
    • Uza, Norimitsu;
    • Kodama, Yuzo;
    • Asada, Masanori;
    • Kawaguchi, Michiya;
    • Masui, Toshihiko;
    • Mizumoto, Masaki;
    • Yazumi, Shujiro;
    • Matsumoto, Shigemi;
    • Takaori, Kyoichi;
    • Morita, Satoshi;
    • Muto, Manabu;
    • Uemoto, Shinji;
    • Chiba, Tsutomu
    Publication type:
    Article
    13
    14
    15

    Clinical features of Japanese patients with colonic angiodysplasia.

    Published in:
    Journal of Gastroenterology & Hepatology, 2008, v. 23, n. 8pt2, p. e363, doi. 10.1111/j.1440-1746.2007.05126.x
    By:
    • Ueno, Satoru;
    • Nakase, Hiroshi;
    • Kasahara, Katsuhiro;
    • Uza, Norimitsu;
    • Kitamura, Hiroshi;
    • Inoue, Satoko;
    • Mikami, Sakae;
    • Matsuura, Minoru;
    • Chiba, Tsutomu
    Publication type:
    Article
    16
    17
    18
    19
    20
    21

    Laminin 511 is a target antigen in autoimmune pancreatitis.

    Published in:
    Science Translational Medicine, 2018, v. 10, n. 453, p. 1, doi. 10.1126/scitranslmed.aaq0997
    By:
    • Shiokawa, Masahiro;
    • Kodama, Yuzo;
    • Sekiguchi, Kiyotoshi;
    • Kuwada, Takeshi;
    • Tomono, Teruko;
    • Kuriyama, Katsutoshi;
    • Yamazaki, Hajime;
    • Morita, Toshihiro;
    • Marui, Saiko;
    • Sogabe, Yuko;
    • Kakiuchi, Nobuyuki;
    • Matsumori, Tomoaki;
    • Mima, Atsushi;
    • Nishikawa, Yoshihiro;
    • Ueda, Tatsuki;
    • Tsuda, Motoyuki;
    • Yamauchi, Yuki;
    • Sakuma, Yojiro;
    • Maruno, Takahisa;
    • Uza, Norimitsu
    Publication type:
    Article
    22
    23
    24
    25
    26
    27

    Safety and efficacy of neoadjuvant chemoradiotherapy with moderately hypofractionated intensity‐modulated radiotherapy for resectable pancreatic cancer: A prospective, open‐label, phase II study.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 18, p. 18611, doi. 10.1002/cam4.6470
    By:
    • Masui, Toshihiko;
    • Nagai, Kazuyuki;
    • Anazawa, Takayuki;
    • Kasai, Yosuke;
    • Yogo, Akitada;
    • Yoshimura, Michio;
    • Mizowaki, Takashi;
    • Uza, Norimitsu;
    • Fukuda, Akihisa;
    • Matsumoto, Shigemi;
    • Kanai, Masashi;
    • Isoda, Hiroyoshi;
    • Kawaguchi, Yoshiya;
    • Uemoto, Shinji;
    • Hatano, Etsuro
    Publication type:
    Article
    28

    Publisher Correction: Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study.

    Published in:
    2025
    By:
    • Okabe, Makoto;
    • Yamamoto, Shuji;
    • Shiokawa, Masahiro;
    • Hisamatsu, Tadakazu;
    • Yamazaki, Hajime;
    • Nakanishi, Risa;
    • Hamada, Kensuke;
    • Kitamoto, Hiroki;
    • Kuwada, Takeshi;
    • Uza, Norimitsu;
    • Sakatani, Aki;
    • Fujii, Toshimitsu;
    • Ohno, Masashi;
    • Matsuura, Minoru;
    • Shibuya, Tomoyoshi;
    • Ohmiya, Naoki;
    • Ooi, Makoto;
    • Hoshi, Namiko;
    • Moriya, Kei;
    • Tsuchiya, Kiichiro
    Publication type:
    Correction Notice
    29

    Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study.

    Published in:
    Journal of Gastroenterology, 2025, v. 60, n. 1, p. 86, doi. 10.1007/s00535-024-02176-x
    By:
    • Okabe, Makoto;
    • Yamamoto, Shuji;
    • Shiokawa, Masahiro;
    • Hisamatsu, Tadakazu;
    • Yamazaki, Hajime;
    • Nakanishi, Risa;
    • Hamada, Kensuke;
    • Kitamoto, Hiroki;
    • Kuwada, Takeshi;
    • Uza, Norimitsu;
    • Sakatani, Aki;
    • Fujii, Toshimitsu;
    • Ohno, Masashi;
    • Matsuura, Minoru;
    • Shibuya, Tomoyoshi;
    • Ohmiya, Naoki;
    • Ooi, Makoto;
    • Hoshi, Namiko;
    • Moriya, Kei;
    • Tsuchiya, Kiichiro
    Publication type:
    Article
    30

    Anti-integrin αvβ6 autoantibody in primary sclerosing cholangitis: a Japanese nationwide study.

    Published in:
    Journal of Gastroenterology, 2025, v. 60, n. 1, p. 118, doi. 10.1007/s00535-024-02169-w
    By:
    • Yasuda, Muneji;
    • Shiokawa, Masahiro;
    • Kuwada, Takeshi;
    • Nishikawa, Yoshihiro;
    • Nakanishi, Risa;
    • Takimoto, Ikuhisa;
    • Chikugo, Koki;
    • Yokode, Masataka;
    • Muramoto, Yuya;
    • Matsumoto, Shimpei;
    • Nakamura, Takeharu;
    • Ota, Sakiko;
    • Matsumori, Tomoaki;
    • Kuroda, Keiko;
    • Hachiya, Takahisa;
    • Yamazaki, Hajime;
    • Uza, Norimitsu;
    • Kodama, Yuzo;
    • Chiba, Tsutomu;
    • Fujisawa, Toshio
    Publication type:
    Article
    31

    Anti-integrin αvβ6 autoantibodies in patients with primary sclerosing cholangitis.

    Published in:
    Journal of Gastroenterology, 2023, v. 58, n. 8, p. 778, doi. 10.1007/s00535-023-02006-6
    By:
    • Yoshida, Hiroyuki;
    • Shiokawa, Masahiro;
    • Kuwada, Takeshi;
    • Muramoto, Yuya;
    • Ota, Sakiko;
    • Nishikawa, Yoshihiro;
    • Maeda, Hirona;
    • Kakiuchi, Nobuyuki;
    • Okamoto, Kanako;
    • Yamazaki, Hajime;
    • Yokode, Masataka;
    • Nakamura, Takeharu;
    • Matsumoto, Shimpei;
    • Hirano, Tomonori;
    • Okada, Hirokazu;
    • Marui, Saiko;
    • Sogabe, Yuko;
    • Matsumori, Tomoaki;
    • Mima, Atsushi;
    • Uza, Norimitsu
    Publication type:
    Article
    32

    Essential role of Notch/Hes1 signaling in postnatal pancreatic exocrine development.

    Published in:
    Journal of Gastroenterology, 2021, v. 56, n. 7, p. 673, doi. 10.1007/s00535-021-01779-y
    By:
    • Kuriyama, Katsutoshi;
    • Kodama, Yuzo;
    • Shiokawa, Masahiro;
    • Nishikawa, Yoshihiro;
    • Marui, Saiko;
    • Kuwada, Takeshi;
    • Sogabe, Yuko;
    • Kakiuchi, Nobuyuki;
    • Tomono, Teruko;
    • Matsumori, Tomoaki;
    • Mima, Atsushi;
    • Morita, Toshihiro;
    • Ueda, Tatsuki;
    • Tsuda, Motoyuki;
    • Yamauchi, Yuki;
    • Sakuma, Yojiro;
    • Ota, Yuji;
    • Maruno, Takahisa;
    • Uza, Norimitsu;
    • Kageyama, Ryoichiro
    Publication type:
    Article
    33
    34
    35
    36

    ELF3 suppresses gallbladder cancer development through downregulation of the EREG/EGFR/mTOR complex 1 signalling pathway.

    Published in:
    Journal of Pathology, 2023, v. 261, n. 1, p. 28, doi. 10.1002/path.6144
    By:
    • Nakamura, Takeharu;
    • Nishikawa, Yoshihiro;
    • Shiokawa, Masahiro;
    • Takeda, Haruhiko;
    • Yokode, Masataka;
    • Matsumoto, Shimpei;
    • Muramoto, Yuya;
    • Ota, Sakiko;
    • Yoshida, Hiroyuki;
    • Okada, Hirokazu;
    • Kuwada, Takeshi;
    • Marui, Saiko;
    • Matsumori, Tomoaki;
    • Maruno, Takahisa;
    • Uza, Norimitsu;
    • Kodama, Yuzo;
    • Hatano, Etsuro;
    • Seno, Hiroshi
    Publication type:
    Article